$1 Million in Research Grants Awarded by the Leukemia Research Foundation

(NORTHFIELD, Ill.) The Leukemia Research Foundation (LRF) is proud to announce the recipients of its 2017-2018 funding of blood cancer research. The LRF awards one-year, $100,000 grants to support research projects that will result in a better understanding blood cancers, as well as bolster the careers of “New Investigators”, a key niche of innovative scientists who are beginning to establish their own laboratories and are no longer under the tutelage of a senior scientist mentor. The funding enables New Investigators to act on their ideas, and try new procedures and experiments that will lead to significant breakthroughs.

The list of institutions, grantees, and projects funded is as follows.

Francine E. Garrett-Bakelman, M.D., Ph.D., University of Virginia
Determination of age-appropriate risk classification in Acute Myeloid Leukemia

Austin L. Brown, Ph.D., Baylor College of Medicine
Pharmacometabolomic Biomarkers of Neuropsychological Outcomes following Pediatric Acute Lymphoblastic Leukemia Therapy

Meelad M. Dawlaty, Ph.D., Albert Einstein College of Medicine
Epigenetic regulation of hematopoietic malignancies by Tet enzymes

Wei Du, Ph.D., West Virginia University
Targeting niche-stem cell interaction for leukemia therapy

Katherine Hyde, Ph.D., University of Nebraska Medical Center
The Role of CBFB-MYH11 in the Maintenance of Leukemia Stem Cells

Jing Li, M.D., Ph.D., Shanghai Normal University, Shanghai, China
The role of Sirt2 in the pathogenesis of acute myeloid leukemia

Sheng Li, Ph.D., Jackson Laboratory, Bar Harbor, ME
Uncovering Hydroxymethylation-mediated 3D Genome Dynamics in AML

Parvathi Ranganathan, Ph.D., The Ohio State University
Inhibition of PRMT5: a double-edged sword strategy to target acute Graft-versus-Host Disease and relapse/residual disease

Sarah A. Slavoff, Ph.D., Yale University
Discovery and functional evaluation of non-annotated microproteins in leukemia cells

Britta Will, Ph.D., Albert Einstein College of Medicine
Leukemia maintenance through chaperone-mediated autophagy

“Every year the work of thousands of volunteers and supporters of the LRF culminates in this commitment of funds to find cures and improve treatments for blood cancers,” said LRF Executive Director Kevin Radelet. “The awards not only help to alleviate a gap in research funding but also ensures that important discoveries are facilitated early in the process.”

The proposals were organized by specialty then matched to the expertise of the LRF’s Medical Advisory Board (MAB) by Board Chairperson Patrick J. Stiff, M.D., Director of the Cardinal Bernardin Cancer Center at Loyola University Medical Center in Maywood, Ill. Each proposal was thoroughly evaluated and scored using the same scoring system adhered to by the National Institutes of Health. The full MAB membership, senior scientists from every area of hematologic malignancy research, discussed the final projects in person on June 10, 2017. Final recommendations were made and forwarded to the LRF.

Funding for the FY 2017-2018 cycle will begin on July 1, 2017.  For more information about the LRF and its Hollis Brownstein Research Grants Program, visit www.allbloodcancers.org or call 847-424-0600.


About The Leukemia Research Foundation (LRF)

The Leukemia Research Foundation, a CharityNavigator.org 4-Star Charity headquartered in Northfield, Ill., is committed to funding research and providing support to people affected by blood cancers. The LRF is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. For 70 years, thousands of volunteers and 24 chapters have helped the LRF raise more than $70 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world, provide patient financial assistance, and offer educational and emotional support for patients and their families.

LRF information is available at www.allbloodcancers.org, or by calling 847.424.0600.


For additional information call:
Carl Alston, Director of Communications

Category Tag(s): Current News